Actively Recruiting

Phase 2
Phase 3
Age: 30Years - 70Years
MALE
NCT04263025

AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft

Led by Hackensack Meridian Health · Updated on 2025-10-22

100

Participants Needed

1

Research Sites

374 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study aims at evaluating if placement of CLARIX® CORD 1K during robotic prostatectomy decreases the time to achieve complete erectile and urinary function after the surgery. As part of the study, the patient will be asked to answer various questions after the surgery regarding sexual and urinary function.

CONDITIONS

Official Title

AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft

Who Can Participate

Age: 30Years - 70Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Male aged between 30 and 70 years old
  • Primary diagnosis of organ confined prostate cancer
  • Scheduled to undergo bilateral, nerve-sparing robot-assisted radical prostatectomy
  • Patient has ICIQ-SF score less than 6
  • Patient has no erectile dysfunction (IIEF-6 score 26 or higher)
  • Willing to return for all visits as defined in the protocol
  • Willing to follow the instructions of the Investigator
  • Provided written informed consent
Not Eligible

You will not qualify if you...

  • Previous history of pelvic radiation
  • Previous history of simple prostatectomy or transurethral prostate surgery
  • Previous history of systemic therapy for prostate cancer
  • Neurogenic bladder
  • Body weight less than 50 kg (110 pounds) or body mass index greater than 40 kg/m2
  • History of open pelvic surgery within 5 years except for hernia repair
  • Scheduled to undergo chemotherapy, radiation, hormone therapy, or open surgery during the study period
  • Any neurologic or psychiatric disorder that might affect post-surgical assessments
  • Received investigational drug within 30 days prior to study or planned administration of another investigational product during study
  • Previous history of anaphylaxis or hypersensitivity to liposomal amphotericin-B

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Hackensack University Medical Center

Hackensack, New Jersey, United States, 07601

Actively Recruiting

Loading map...

Research Team

S

Sharon Seidman, RN

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here